Pharmacoeconomic analysis of mizolastine and cetirizine in treatment of chronic urticaria
HU De-jian
LI Yong-jian
XIAO Xuan
Abstract：Objective To evaluate the cost-effectiveness (C/E) of mizolastine and cetirizine in treatment of chronic urticaria.Methods Ninety-six cases with chronic urticaria were randomized into group A and group B.They were administered with mizolastine and cetirizine for 14 d,qd,10 mg/time,respectively.The curative effects were observed and C/E analysis was made by cost economics approach.Results The total effective rates of group A and group B were 66.67％ and 64.58％,respectively.There were no significant differences in total effective rates between the two groups ( P ＞ 0.05 ).The C/E of group B (0.22 ) was significantly lower than that of group A (0.85).The difference between the two groups had a statistical significance (P ＜ 0.05).Conclusion The C / E of cetirizine is low in treatment of chronic urticaria.
Keywords：Chronic urticariaMizolastineCetirizineCost-effectiveness analysis
Publication Date：2012-01-01
Online Publishing Date：2026-09-14(First online date of this platform, not the publication date of the document)